Wipro, BEL, Paytm, Aurobindo Pharma: Orders, Investments, USFDA in focus

Market
C
CNBC TV18•14-12-2025, 13:28
Wipro, BEL, Paytm, Aurobindo Pharma: Orders, Investments, USFDA in focus
- •Wipro expanded its partnership with Google Cloud, adopting Gemini Enterprise across its global operations to boost productivity and embed AI-led workflows.
- •Godawari Power & Ispat approved a ₹1,625-crore investment to scale up its battery energy storage manufacturing project to reach 40 GWh annual capacity.
- •KEC International won new orders worth ₹1,150 crore, the largest ever for its India T&D business, including a 765 kV transmission line and substation project.
- •Aurobindo Pharma's API facility received a Form 483 with three procedural observations from the USFDA after an inspection.
- •Bharat Electronics (BEL) secured additional orders worth ₹776 crore since its last disclosure, bolstering its order inflows for the year.
Why It Matters: These company updates signal market activity and potential stock impacts.
✦
More like this
Loading more articles...





